menu Search
Search Drug Information, Images & Medical News

Search Drug Information, Images & Medical News | CIMS India

Advanced Search

 

MORE
Tezepelumab cuts oral corticosteroid use without compromising asthma control 09 Jun 2026
Tezepelumab demonstrates steroid-sparing potential in patients with severe asthma, reducing maintenance oral corticosteroid use while maintaining asthma control, as shown in the phase III SUNRISE study.
Early CKD screening in CAD patients must include eGFR, UACR: study
09 Jun 2026
Rapid response to obesity medications tied to greater weight loss
09 Jun 2026
Healthy low-carb, low-fat diets may lower CHD risk
09 Jun 2026
Daraxonrasib makes history in one of the deadliest cancers 09 Jun 2026
Daraxonrasib—an oral, potent RAS(ON) multi-selective, tri-complex inhibitor—demonstrates unprecedented survival benefits in individuals with previously treated metastatic pancreatic adenocarcinoma (mPDAC) in the landmark phase III RASolute 302 study.
Oral semaglutide provides limited benefit in individuals with early AD
08 Jun 2026
First-in-class P-CAB a game-changer in H. pylori eradication
08 Jun 2026
Glycaemic control in T2D better with CGM vs self-monitoring
08 Jun 2026
Daraxonrasib makes history in one of the deadliest cancers
09 Jun 2026
Oral semaglutide provides limited benefit in individuals with early AD
08 Jun 2026
First-in-class P-CAB a game-changer in H. pylori eradication
08 Jun 2026
Glycaemic control in T2D better with CGM vs self-monitoring
08 Jun 2026
AI and social media has its place in ENT practice. We cannot avoid the advent of technology, but it must be used with caution.
08 Jun 2026
Are doctors in white coat more trustworthy?
08 Jun 2026
High choline, betaine intakes may improve cognitive performance in older adults with obesity
08 Jun 2026
Evaluation of patients presenting to a multidisciplinary lymphatic centre
08 Jun 2026
EPICS-III shows saroglitazar potential for select PBC patients
08 Jun 2026
Not every surgery ends up well. When unforseen outcomes happen, prior preparation and sincere communication can go a long way to softening the emotional impact on all parties involved.
08 Jun 2026
Electroacupuncture a potential nonpharmacologic option for managing postherpetic neuralgia
07 Jun 2026
Advertisement
MORE
Hard Truths, Soft Landing: A Compassionate Guide to Breaking Bad News
Doctors 1 point
Addressing Vaccine Hesitancy in Older Adults: Effective Communication Strategies for Physicians
Doctors
Championing Public Health Advocacy for Change-Makers
Doctors
Advertisement
Advertisement

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Learn More About Us

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs